TG Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About TG Therapeutics Inc.
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, it has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. Its pipeline includes UBLITUXIMAB, SUB-Q UBLITUXIMAB, and AZER-CEL. Geographically, it generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from the international market.
/ 
Frequently asked questions
To buy TG Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for TG Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for TG Therapeutics Inc. is TGTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
TG Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade TG Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, TG Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include TG Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like TG Therapeutics Inc. or others.